Evidence map›Paper›PMID 32015903›Full record

ArticleCentral European journal of urology2019

Efficacy of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder cancer and quality of surgery: post-hoc analysis of а prospective randomized study.

Alexander Rolevich, Alexander Minich, Vladimir Vasilevich, Alexander Zhegalik, Andrey Mokhort, Tatiana Nabebina, Sergey Krasny, Sergey Polyakov, Oleg Sukonko

Open access · greenAbstract read
In one paragraph

Article in Central European journal of urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 syntheses or guidelines pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alexander RolevichDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Alexander MinichDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Vladimir VasilevichDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Alexander ZhegalikDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Andrey MokhortDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Tatiana NabebinaDepartment of Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Sergey KrasnyDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Sergey PolyakovDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Oleg SukonkoDepartment of Urology and Pathology, N.N. Alexandrov National Research Cancer Center, Minsk, Belarus.
Nagasaki University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis paper aims to evaluate the influence of quality of transurethral resection in patients with non-muscle invasive bladder cancer on the benefit of fluorescent cystoscopy-assisted transurethral resection in the post hoc analysis of the single-center randomized controlled trial. MATERIAL AND

methodsWe retrospectively analyzed the results of the prospective randomized study assessing the efficacy of fluorescent cystoscopy-assisted transurethral resection. The quality of transurethral resection was defined on the basis of a separate retrospective study estimating the variability in recurrence risk for the individual surgeon. The subgroup analysis of fluorescent cystoscopy-assisted transurethral resection efficacy depending on surgical experience was performed.

resultsOf 377 eligible patients, transurethral resection was performed in 365 (97%) by surgeons with available grading information. Two 'experienced' surgeons performed 238 (63%) of all transurethral resections and three 'less experienced' surgeons completed 127 (34%) surgeries. The two surgical groups were comparable with respect to basic prognostic factors and subsequent therapy. The median follow-up was 56 months.In the total cohort of patients, fluorescent cystoscopy significantly decreased the risk of recurrence with hazard ratio 0.58 (p = 0.004). In the 'experienced surgeons' subgroup the benefit of fluorescent cystoscopy was not significant (hazard ratio 0.81, p = 0.34), whereas the 'less experienced' subgroup showed a marked difference in favor of fluorescent cystoscopy-assisted transurethral resection (hazard ratio 0.31, p = 0.001), with a P-value for interaction of 0.021.

conclusionsBaseline quality of surgery may be a significant interacting factor affecting the magnitude of the benefit of fluorescent cystoscopy-assisted transurethral resection in patients with non-muscle invasive bladder cancer.

Indexed as

cystoscopyneoplasm recurrenceoptical imagingretrospective studiesurinary bladder neoplasm

Identifiers

PMID32015903
PMCPMC6979560
OpenAlexW3007864103

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.